Please assess the completion status of the following clinical trial:

Trial Title: Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Infants that are 25 0/7 - 31 6/7 weeks gestation~* Infants who require Continuous Positive Airway Pressure (CPAP) or Positive Pressure Ventilation ( PPV) during delivery room resuscitation.~Exclusion Criteria:~* Refusal of consent~* Known complex congenital anomalies of the heart or lungs~* Known major genetic defects~* Hydrops fetalis

- Gender: ALL
- Minimum Age: 1 Minute
- Maximum Age: 2 Minutes
- Healthy Volunteers: f

Study Arms:
- Placebo 20ppm (Type: PLACEBO_COMPARATOR): Nitrogen at 20 ppm at the beginning of study start with gradual taper at 10 minutes of the study and completely off by 17 minutes of the study
- Inhaled Nitric Oxide (iNO) 20 ppm (Type: EXPERIMENTAL): Inhaled Nitric Oxide 20 ppm at the beginning of study start with gradual taper at 10 minutes of the study and completely off by 17 minutes of the study

Based on this trial design, predict the completion outcome and termination type (if applicable).